Our Research and Development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.  

We are the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on: Alzheimer’s disease, Depression, Parkinson’s disease, and Schizophrenia.